035 Epidemiology, Risk Factors and Survival of Aki Patients Treated by CRRT - A Study From Rural India

Abstract

and death were evaluated. The AKIN classification was used to define acute injury. Results: We identified 555 patients admitted to clinical and surgical wards, corresponding to 1,49% of the total number of patients hospitalized in the period, who was submited into hemodialyses and classified as having acute renal failure (lower incidence than that found in the literature-3.8%), of which 47,9% women and 52,1% men, with a mean age of 75,7 years. The double lumen catheter was the only type of vascular access used; peritoneal dialysis wasn't indicated for these patients. Systemic arterial hypertension was the main comorbidity presented, affecting 45% of the patients, followed by diabetes (27.8% of the cases). The causes of acute renal injury were:-septic (pneumonia 40%) responsible for 52%, cardiogenic shock 16%, major surgeries 15% and drug induced nephropathy 12%. There was recovery of renal function in 13.3% (lower than that found in the literature) with a 45,05% evolution for outpatient dialysis and the mortality rate was 41,80%. The mortality found was compatible with the data present in the literature, being a clinical entity with a high mortality rate. Conclusion: Despite the medical advances of recent years, acute dialysis renal failure, is a pathological entity with a high degree of mortality. Septic conditions, especially pneumonia, contribute to mortality and are among the main causes of renal impairment in patients with acute renal failure.

COVID-19-associated AKI

“…There is significant geographic variation in reported incidence of AKI. Along with the low incidences in China, the incidences of reported AKI in parts of Africa and Southern India are peculiarly low with most reports stating an incidence between 4 and 7% [28–31]. In contrast, the AKI incidence rate of 36–50% in South America was comparable with those observed in Europe and Northern America [32,33].…”

Clinical and Biochemical Characteristics of COVID-19-Associated Acute Kidney Injury (COVAKI): A Proof-of-Concept Case-Control Study

“…Sampathkumar et al collected and analyzed the data of 718 adult patients with COVID-19 from April to November 2020 and concluded that 7% developed AKI with a mortality of 44%. These patients with AKI had raised D-dimer and low albumin levels[16]. Sindhu et al carried out an observational study among 2650 COVID-19 patients between May 2020 and October 2020.…”